Title	Publication Date	Language	Citations
A big step for MYC-targeted therapies	2024/04/01	English
Exploiting the metabolic vulnerability of circulating tumour cells	2024/04/01	English
Label-free optical imaging for brain cancer assessment	2024/04/01	English
The evolving posology and administration of immune checkpoint inhibitors: subcutaneous formulations	2024/04/01	English
Gastric cancer immunosuppressive microenvironment heterogeneity: implications for therapy development	2024/04/01	English
Advisory Board and Contents	2024/04/01	English
Subscription & copyright page	2024/04/01	English
Nanomedicine to aid immunogenic cell death (ICD)-based anticancer therapy	2024/03/01	English
Beyond probiotics: postbiotics sensitize cancer cells to immune checkpoint inhibitors	2024/01/01	English
It’s all about the base: stromal cells are central orchestrators of metastasis	2024/03/01	English
Bacteria-derived L-lactate fuels cervical cancer chemoradiotherapy resistance	2024/02/01	English
Noncanonical translation of circRNAs drive antitumor immunity	2024/02/01	English
FBXW10: a male-biased E3 ligase in liver cancer	2023/11/01	English
Successfully targeting the cancer system with metronomics for medulloblastoma	2023/12/01	English
Anxiolytics cause anxiety in pancreatic cancer	2023/11/01	English
Modulating β-catenin homeostasis for cancer therapy	2024/03/01	English
Into the era of mycobiome-driven cancer research	2024/03/01	English
Puzzling phenomenon: adult-onset cancer predisposition and pediatric cancer	2024/03/01	English
Insights into LINE-1 reverse transcription guide therapy development	2024/04/01	English
Tumor immune escape by autotaxin: keeping eosinophils at bay	2024/04/01	English
Subscription & copyright page	2024/03/01	English
Advisory Board and Contents	2024/03/01	English
The anti-cancer immune response in breast cancer: current and emerging biomarkers and treatments	2024/03/01	English
Poised epigenetic states dictate metastatic fitness	2024/04/01	English
Beyond binary: bridging neutrophil diversity to new therapeutic approaches in NSCLC	2024/02/01	English
Impact of tissue-agnostic approvals on management of primary brain tumors	2024/03/01	English
Benefits and opportunities of the transgenic Oncopig cancer model	2024/03/01	English
Precise timing of audiovisual stimulation conquers chemobrain	2024/04/01	English
Fusion genes in pancreatic tumors	2024/02/01	English
Interferon signaling restrains renal cell carcinoma heterogeneity	2023/11/01	English